PPARGC1A and diabetes mellitus: To fill this gap and define the underlying molecular mechanisms, this study used db/db mice as a diabetes model to investigate the effect of pharmacological TNKS inhibition, focusing on PGC-1α-regulated oxidative metabolism in WAT and skeletal muscle.